WHO grants Emergency Use Listing to BioFire’s Global Fever Special Pathogens Panel, enabling rapid detection of Ebola and 15 ...

Diadem receives a US patent expanding protection for its AlzoSure Predict blood assay, which detects U-p53AZ, a biomarker ...

Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.

Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.

A Penn State-led team developed a rapid syphilis test that detects low antibody titers in one step, with up to 46% stronger ...

The companies will collaborate with AstraZeneca to advance local lab testing for a prostate cancer genomic instability ...

Beckman Coulter Diagnostics appoints Catherine Jennings, formerly of Boston Scientific as president to lead global operations ...

Keck Medicine of USC has begun a trial to assess a blood test for early breast cancer detection, evaluating its use alongside ...

Aignostics launches HETA Clinical, an AI suite for assessing H&E slide quality and tumor content, aiming to reduce failed ...

Nabsys launches RepX, a pipeline on its Navigator platform that analyzes up to 23 disease loci in one run using Electronic ...

Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...